NEW YORK, February 5, 2021 / PRNewswire / –
WHY: Rosen Law Firm, a global investment rights law firm, is reminding customers of the securities of Minerva Neurosciences, Inc. (NASDAQ: NERV) between May 15, 2017 and November 30, 2020, inclusive (the “class time”), of the important February 8, 2021 progressive plaintiff date.
SO WHAT: If you purchased Minerva securities during Class Time you may be entitled to compensation without incurring any costs or expenses through a contingent tax arrangement.
WHAT TO DO: To join the Minerva class action, visit http://www.rosenlegal.com/cases-register-2004.html or call Phillip Kim, Esq. no fees at 866-767-3653 or email [email protected] no [email protected] for information about the class activity. A class action lawsuit has already been filed. If you want to be the main complaint, you have to move the Court not to exceed February 8, 2021. A chief planner is a representative party acting on behalf of other class members in administering the law.
WHY: We encourage investors to choose certified advice with a history of success in management positions. Issuing companies often do not have comparable knowledge or resources. Rosen Law Firm represents investors around the globe, focusing their use in securities class actions and legalizing shareholder sub-securities. Rosen Law Firm has executed the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was ranked at No. 1 by ISS Securities Class Action Services for the number of securities class action settlements in 2017. The firm has been ranked in the top 3 annually since 2013 and has get back hundreds of millions of dollars to investors. In 2019 alone the company took over $ 438 million for investors. In 2020 founding partner Laurence Rosen named by the law360 as the Titan Bar of Plaintiffs. Many of the firm’s lawyers are recognized by Lawdragon and Super Lawyers.
CASE INFORMATION: According to the lawsuit, defendants during the Class Period made false and / or misleading statements and / or failed to: (1) the truth of the feedback received from the FDA regarding the meeting “End of Stage 2”; (2) that the Level 2b roluperidone commercial formulation study was not used and was performed directly externally United States; (3) when a Phase 3 study failed to meet its main and secondary high school points, that study was unable to provide robust evidence of effectiveness; (4) Minerva Plan to use the Level mix 2b and Stage 3 inspections would be “highly unlikely” to support the submission of a New Drug Request (“NDA”); (5) reliance on both of these tests in NDA submission would result in “substantial review cases” because the tests were inadequate and not well controlled; and (6) as a result, the defendants’ public statements were misleading and misleading at all material times. Once the real details entered the market, the lawsuit alleges that investors suffered damage.
To join the Minerva class action, visit http://www.rosenlegal.com/cases-register-2004.html or call Phillip Kim, Esq. no fees at 866-767-3653 or email [email protected]senlegal.com no [email protected] for information about the class activity.
No classes were confirmed. Until a class is confirmed, you will not be represented by an adviser unless you book one. You can choose a consultant of your choice. You can also remain an absent class member and do nothing at this stage. An investor’s ability to share in any future improvement is not dependent on serving as a key complaint.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.
Lawyer advertising. Previous results do not guarantee a similar result.
Contact information:
Laurence Rosen, Esq.
Phillip Kim, Esq.
Law Firm Rosen, PA
275 Madison Avenue, 40th floor
New York, NY 10016
Phone: (212) 686-1060
Hole free: (866) 767-3653
Fax: (212) 202-3827
[email protected]
[email protected]
[email protected]
www.rosenlegal.com
SOURCE Rosen Law Firm, PA
Related Links
www.rosenlegal.com